[1] Veldhoen M,Uyttenhove C,van Snick J,et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.Nat Immunol, 2008,9:1341-1346. [2] Dardalhon V,Awasthi A,Kwon H,et al.IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.Nat Immunol,2008,9:1347-1355. [3] Noelle RJ,Nowak EC. Cellular sources and immune functions of interleukin-9.Nat Rev Immunol,2010,10:683-687. [4] Stassen M,Schmitt E,Bopp T. From interleukin-9 to T helper 9 cells.Ann N Y Acad Sci,2012,1247:56-68. [5] Harrington LE,Hatton RD,Mangan PR,et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat Immunol,2005,6:1123-1132. [6] Leech MD,Grencis RK. Induction of enhanced immunity to intestinal nematodes using IL-9-producing dendritic cells.J Immunol,2006,176:2505-2511. [7] Jimenez-Sousa MA,Almansa R,de la Fuente C, et al. Increased Th1,Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin.Eur Cytokine Netw,2010,21:84-91. [8] Nan XP,Zhang Y,Yu HT,et al. Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B. Viral Immunol,2012,25:21-28. [9] Nowak EC, Noelle RJ. Interleukin-9 as a T helper type 17 cytokine. Immunology,2010,131:169-173. [10] Li E, Zhou P,Petrin Z,et al. Mast cell-dependent control of Giardia lamblia infections in mice.Infect Immun,2004,72:6642-6649. [11] Li H,Rostami A. IL-9: basic biology, signaling pathways in CD4 + T cells and implications for autoimmunity. J Neuroimmune Pharmacol,2010,5:198-209. |